Prosecution Insights
Last updated: October 25, 2026

VERADERMICS INCORPORATED

Technology area: Biotechnology & Pharmaceuticals

47 pending office actions • 3 art units • 5 examiners • 0 of 47 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

VERADERMICS INCORPORATED has 49 pending office actions in Biotechnology & Pharmaceuticals. The portfolio is assigned among 5 distinct examiners and 3 distinct art units, so the workload is concentrated within a relatively small examiner and technical-unit group.

HENLEY III, RAYMOND J is the busiest examiner, with 45 pending actions. This concentration makes that examiner relationship central to prosecution planning. Counsel should consider coordinated review of claim amendments, interview opportunities, and recurring office-action issues for the HENLEY matters, while separately tracking the actions assigned to the other examiners and art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

47
Total Pending OAs
29
Non-Final OAs
16
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (15%)
31
Medium (66%)
9
Easy (19%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only9 (19%)
§112 only4 (9%)
Double-patenting only5 (11%)
Double-patenting + other22 (47%)
Multi-statute (no §101)7 (15%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

43
Life Sciences
91% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
9% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

470 h
Manual time on pending OAs
94 h
Time saved (low, 20%)
164 h
Time saved (mid, 35%)
4.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HENLEY III, RAYMOND J 43 83.5% +2.3%
ALLEN, ROBERT F 1 72.9% +62.6%
HEITMEIER, KENDALL NICOLE 1 65.1% +41.1%
AHMED, TASNIM M 1 81.4% +4.9%
DARB, HAMZA A. 1 74.5% +31.1%

Quick Wins (38)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19303300 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 38d overdue
19329494 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 8d overdue
19245208 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 4d overdue
19094703 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 19d
19215242 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 33d
19572691 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19572667 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19569918 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19260035 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 28d overdue
19258817 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 28d overdue
19267447 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 24d overdue
19447910 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19445445 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
19267464 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J —
18686168 COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA HEITMEIER, KENDALL NICOLE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18283685 PERILESIONAL TREATMENT OF SKIN CONDITIONS DARB, HAMZA A. 15d
18659756 MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY ALLEN, ROBERT F —
18686168 COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA HEITMEIER, KENDALL NICOLE —

Top Art Units

Art UnitApps
1629 43
3783 3
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19572691 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Mar 19, 2026
19572667 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Non-Final OA — Pending Mar 19, 2026
19569918 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Mar 17, 2026
19570012 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Mar 17, 2026
19569963 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Mar 17, 2026
19546276 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Non-Final OA — Pending Feb 20, 2026
19546257 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Feb 20, 2026
19542655 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 17, 2026
19539689 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 13, 2026
19538745 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 12, 2026
19538689 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Feb 12, 2026
19449371 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112Other Non-Final OA — Pending Jan 14, 2026
19447910 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §102§103§112Other Non-Final OA — Pending Jan 13, 2026
19445445 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §102§103§112Other Non-Final OA — Pending Jan 09, 2026
19444686 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 09, 2026
19445410 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §102§103§112DP Non-Final OA — Pending Jan 09, 2026
19443936 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 08, 2026
19442979 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Non-Final OA — Pending Jan 07, 2026
19442899 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112DP Final Rejection — Pending Jan 07, 2026
19427815 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Dec 19, 2025
19420555 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Dec 15, 2025
19402812 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112Other Non-Final OA — Pending Nov 26, 2025
19397854 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Nov 21, 2025
19329494 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Final Rejection 8d overdue Pending Sep 15, 2025
19329476 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Non-Final OA — Pending Sep 15, 2025
19328077 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Non-Final OA — Pending Sep 12, 2025
19308124 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 DP Final Rejection — Pending Aug 22, 2025
19303300 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection 38d overdue Pending Aug 18, 2025
19267464 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112Other Non-Final OA — Pending Jul 11, 2025
19267447 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112Other Non-Final OA 24d overdue Pending Jul 11, 2025
19260035 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112 Non-Final OA 28d overdue Pending Jul 03, 2025
19258817 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103§112Other Non-Final OA 28d overdue Pending Jul 02, 2025
19253703 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Jun 27, 2025
19245208 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA 4d overdue Pending Jun 20, 2025
19242858 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112Other Non-Final OA — Pending Jun 18, 2025
19241304 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Jun 17, 2025
19236933 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Non-Final OA — Pending Jun 12, 2025
19234212 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection — Pending Jun 10, 2025
19230047 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112DP Final Rejection — Pending Jun 05, 2025
19230007 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103DP Final Rejection — Pending Jun 05, 2025
19215242 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §112 Non-Final OA 33d Pending May 21, 2025
19215216 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Non-Final OA — Pending May 21, 2025
19094703 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL HENLEY III, RAYMOND J 1629 §103Other Final Rejection 19d Pending Mar 28, 2025
18659756 MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY ALLEN, ROBERT F 3783 §103§112DP Non-Final OA — Pending May 09, 2024
18686168 COMPOSITIONS AND METHODS FOR TREATMENT OF ALOPECIA AREATA HEITMEIER, KENDALL NICOLE 3781 §102§103§112 Non-Final OA — Pending Feb 23, 2024
18563118 MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY AHMED, TASNIM M 3783 §103 Final Rejection — Pending Nov 21, 2023
18283685 PERILESIONAL TREATMENT OF SKIN CONDITIONS DARB, HAMZA A. 3783 §103 Final Rejection 15d Pending Sep 22, 2023

Managing VERADERMICS INCORPORATED's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does VERADERMICS INCORPORATED have?

VERADERMICS INCORPORATED has 47 pending office actions as of October 2026, spread across 3 art units and 5 examiners.

Which USPTO examiner handles the most VERADERMICS INCORPORATED applications?

Raymond J Henley III has the most, with 43 of VERADERMICS INCORPORATED's pending office actions.

What technology area are VERADERMICS INCORPORATED's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month